To hear about similar clinical trials, please enter your email below
Trial Title:
Patient Perspectives in Squamous Cell Carcinoma Clinical Trials
NCT ID:
NCT05929547
Condition:
Squamous Cell Carcinoma
Conditions: Official terms:
Carcinoma
Carcinoma, Squamous Cell
Conditions: Keywords:
squamous cell carcinoma
Study type:
Observational
Overall status:
Not yet recruiting
Study design:
Time perspective:
Prospective
Summary:
Clinical research participation has historically been heavily biased toward specific
demographics.
This study will invite several participants to gather a wide range of information on
clinical trial experiences for squamous cell carcinoma patients. The aim of the study is
to identify the factors that limit the ability of a person to enroll in, as well as
complete a clinical trial for treatment of squamous cell carcinoma.
People with squamous cell carcinoma who are invited to take part in clinical research
will benefit from the analysis of the data.
Criteria for eligibility:
Study pop:
Patients with squamous cell carcinoma who are actively considering enrolling in a
clinical trial for said condition, but have not yet completed enrollment and
randomization phases.
Sampling method:
Probability Sample
Criteria:
Inclusion Criteria:
- Aged ≥ 18 years old
- Confirmed diagnosis of squamous cell carcinoma
- Subjects willing and able to comply with the protocol for the duration of the study
including undergoing treatment and scheduled visits and examination.
Exclusion Criteria:
- Inability to provide written informed consent
- Is pregnant, breastfeeding or expecting to conceive within the projected duration of
the study
- Enrolled in another research study
Gender:
All
Minimum age:
18 Years
Maximum age:
N/A
Healthy volunteers:
No
Locations:
Facility:
Name:
Power Life Sciences
Address:
City:
San Francisco
Zip:
94107
Country:
United States
Start date:
July 2024
Completion date:
July 2026
Lead sponsor:
Agency:
Power Life Sciences Inc.
Agency class:
Industry
Source:
Power Life Sciences Inc.
Record processing date:
ClinicalTrials.gov processed this data on November 12, 2024
Source: ClinicalTrials.gov page:
https://clinicaltrials.gov/ct2/show/NCT05929547
